vs

Side-by-side financial comparison of Ibotta, Inc. (IBTA) and TACTILE SYSTEMS TECHNOLOGY INC (TCMD). Click either name above to swap in a different company.

TACTILE SYSTEMS TECHNOLOGY INC is the larger business by last-quarter revenue ($103.6M vs $82.5M, roughly 1.3× Ibotta, Inc.). On growth, TACTILE SYSTEMS TECHNOLOGY INC posted the faster year-over-year revenue change (21.0% vs -2.5%). Ibotta, Inc. produced more free cash flow last quarter ($23.3M vs $16.8M). Over the past eight quarters, TACTILE SYSTEMS TECHNOLOGY INC's revenue compounded faster (30.2% CAGR vs -3.1%).

Ibotta, Inc. is an American mobile technology company headquartered in Denver, Colorado. Founded in 2011, the company offers cash back rewards on various purchases through its Ibotta Performance Network and direct to consumer app. Ibotta partners with CPG brands and network publishers to provide these rewards. As of 2024, the company operates solely in the United States. The company's rewards-as-a-service offering, the Ibotta Performance Network, went live in 2022.

Dominion Voting Systems Corporation was a North American company that produced and sold electronic voting hardware and software, including voting machines and tabulators, in Canada and the United States.

IBTA vs TCMD — Head-to-Head

Bigger by revenue
TCMD
TCMD
1.3× larger
TCMD
$103.6M
$82.5M
IBTA
Growing faster (revenue YoY)
TCMD
TCMD
+23.5% gap
TCMD
21.0%
-2.5%
IBTA
More free cash flow
IBTA
IBTA
$6.5M more FCF
IBTA
$23.3M
$16.8M
TCMD
Faster 2-yr revenue CAGR
TCMD
TCMD
Annualised
TCMD
30.2%
-3.1%
IBTA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IBTA
IBTA
TCMD
TCMD
Revenue
$82.5M
$103.6M
Net Profit
$10.6M
Gross Margin
76.4%
78.2%
Operating Margin
10.4%
18.1%
Net Margin
10.3%
Revenue YoY
-2.5%
21.0%
Net Profit YoY
9.4%
EPS (diluted)
$-0.43
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBTA
IBTA
TCMD
TCMD
Q1 26
$82.5M
Q4 25
$88.5M
$103.6M
Q3 25
$83.3M
$85.8M
Q2 25
$86.0M
$78.9M
Q1 25
$84.6M
$61.3M
Q4 24
$98.4M
$85.6M
Q3 24
$98.6M
$73.1M
Q2 24
$87.9M
$73.2M
Net Profit
IBTA
IBTA
TCMD
TCMD
Q1 26
Q4 25
$10.6M
Q3 25
$1.5M
$8.2M
Q2 25
$2.5M
$3.2M
Q1 25
$555.0K
$-3.0M
Q4 24
$9.7M
Q3 24
$17.2M
$5.2M
Q2 24
$-34.0M
$4.3M
Gross Margin
IBTA
IBTA
TCMD
TCMD
Q1 26
76.4%
Q4 25
78.7%
78.2%
Q3 25
79.4%
75.8%
Q2 25
79.2%
74.5%
Q1 25
79.8%
74.0%
Q4 24
84.6%
75.2%
Q3 24
87.7%
75.0%
Q2 24
86.0%
73.9%
Operating Margin
IBTA
IBTA
TCMD
TCMD
Q1 26
10.4%
Q4 25
-1.9%
18.1%
Q3 25
2.8%
12.8%
Q2 25
1.4%
5.2%
Q1 25
-3.3%
-7.4%
Q4 24
13.2%
14.6%
Q3 24
21.0%
9.3%
Q2 24
-24.6%
8.0%
Net Margin
IBTA
IBTA
TCMD
TCMD
Q1 26
Q4 25
10.3%
Q3 25
1.8%
9.6%
Q2 25
2.9%
4.1%
Q1 25
0.7%
-4.9%
Q4 24
11.4%
Q3 24
17.5%
7.1%
Q2 24
-38.6%
5.9%
EPS (diluted)
IBTA
IBTA
TCMD
TCMD
Q1 26
$-0.43
Q4 25
$-0.03
$0.45
Q3 25
$0.05
$0.36
Q2 25
$0.08
$0.14
Q1 25
$0.02
$-0.13
Q4 24
$3.04
$0.40
Q3 24
$0.51
$0.21
Q2 24
$-1.32
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBTA
IBTA
TCMD
TCMD
Cash + ST InvestmentsLiquidity on hand
$164.6M
$83.4M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$249.0M
$218.9M
Total Assets
$479.9M
$273.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBTA
IBTA
TCMD
TCMD
Q1 26
$164.6M
Q4 25
$186.6M
$83.4M
Q3 25
$223.3M
$66.0M
Q2 25
$250.5M
$81.5M
Q1 25
$297.1M
$83.6M
Q4 24
$349.3M
$94.4M
Q3 24
$341.3M
$82.1M
Q2 24
$317.9M
$73.6M
Total Debt
IBTA
IBTA
TCMD
TCMD
Q1 26
Q4 25
$0
$0
Q3 25
$0
Q2 25
Q1 25
Q4 24
$0
Q3 24
$0
$27.0M
Q2 24
$0
$27.8M
Stockholders' Equity
IBTA
IBTA
TCMD
TCMD
Q1 26
$249.0M
Q4 25
$287.7M
$218.9M
Q3 25
$329.6M
$204.9M
Q2 25
$354.1M
$194.9M
Q1 25
$401.3M
$205.6M
Q4 24
$457.3M
$216.6M
Q3 24
$378.0M
$207.9M
Q2 24
$359.7M
$200.7M
Total Assets
IBTA
IBTA
TCMD
TCMD
Q1 26
$479.9M
Q4 25
$525.9M
$273.9M
Q3 25
$569.4M
$259.2M
Q2 25
$600.8M
$273.0M
Q1 25
$639.3M
$280.2M
Q4 24
$678.4M
$297.9M
Q3 24
$598.3M
$287.7M
Q2 24
$556.0M
$278.8M
Debt / Equity
IBTA
IBTA
TCMD
TCMD
Q1 26
Q4 25
0.00×
0.00×
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
0.13×
Q2 24
0.00×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBTA
IBTA
TCMD
TCMD
Operating Cash FlowLast quarter
$30.4M
$17.3M
Free Cash FlowOCF − Capex
$23.3M
$16.8M
FCF MarginFCF / Revenue
28.2%
16.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$80.3M
$40.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBTA
IBTA
TCMD
TCMD
Q1 26
$30.4M
Q4 25
$27.8M
$17.3M
Q3 25
$21.8M
$10.3M
Q2 25
$25.9M
$14.8M
Q1 25
$19.9M
$417.0K
Q4 24
$22.0M
$16.3M
Q3 24
$39.5M
$10.3M
Q2 24
$35.0M
$13.1M
Free Cash Flow
IBTA
IBTA
TCMD
TCMD
Q1 26
$23.3M
Q4 25
$20.3M
$16.8M
Q3 25
$14.5M
$9.2M
Q2 25
$22.2M
$14.4M
Q1 25
$18.0M
$38.0K
Q4 24
$21.8M
$15.9M
Q3 24
$39.2M
$9.3M
Q2 24
$34.8M
$12.6M
FCF Margin
IBTA
IBTA
TCMD
TCMD
Q1 26
28.2%
Q4 25
22.9%
16.2%
Q3 25
17.4%
10.8%
Q2 25
25.8%
18.2%
Q1 25
21.2%
0.1%
Q4 24
22.1%
18.5%
Q3 24
39.8%
12.7%
Q2 24
39.6%
17.3%
Capex Intensity
IBTA
IBTA
TCMD
TCMD
Q1 26
Q4 25
8.5%
0.5%
Q3 25
8.7%
1.3%
Q2 25
4.2%
0.5%
Q1 25
2.2%
0.6%
Q4 24
0.2%
0.5%
Q3 24
0.3%
1.3%
Q2 24
0.2%
0.7%
Cash Conversion
IBTA
IBTA
TCMD
TCMD
Q1 26
Q4 25
1.63×
Q3 25
14.19×
1.26×
Q2 25
10.38×
4.59×
Q1 25
35.78×
Q4 24
1.68×
Q3 24
2.29×
1.99×
Q2 24
3.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBTA
IBTA

Redemption revenue$54.0M65%
Other$19.0M23%
Ad & other revenue$9.5M11%

TCMD
TCMD

Private Insurers$57.6M56%
Medicare$24.6M24%
Durable Medical Equipment Distributors$14.1M14%
Veterans Administration$7.3M7%

Related Comparisons